BillionToOne, a molecular diagnostics company, reported a 47% revenue increase to $123 million in Q3 2026, driven by strong growth in prenatal and oncology testing. The company delivered 206,000 tests, up 25% year-over-year, and improved gross margin to 71%. It raised its full-year 2026 revenue guidance to $460-$470 million, expecting continued profitability despite ongoing investments. BillionToOne also announced the upcoming launch of Northstar Clear, a new MRD test for solid tumors, expanding its cancer testing portfolio.
BillionToOne's Q3 2026 results and raised revenue guidance provide context for readers. For those tracking health-sector stocks, 108 of 150 US stocks rose today on Pluang, with notable gainers including Novavax Inc (NVAX) at USD 10.64 (+9.92%), Envista Holdings Corporation (NVST) at USD 27.17 (+9.69%), and Tenet Healthcare Corporation (THC) at USD 291.92 (+9.46%). These figures are as of Nov 05, 2026 04:11 WIB.
Fox Factory Holding Corp. has appointed Troy Henige as its new Chief Technology Officer (CTO) to lead the company's technology vision, strategy, and product roadmap. This new role aims to enhance innovation, connect engineering strengths across the c...
3M Company has reached a historic $7.35 billion settlement to resolve personal injury claims related to exposure to PFAS, toxic chemicals known as "forever chemicals." The settlement covers about 99% of existing claims, potentially benefiting 115,000...
The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...
Sun Life Financial Inc. announced a quarterly dividend increase to $1.00 per common share, up 4 cents from the previous quarter, payable on December 31, 2026, to shareholders of record as of November 25, 2026. Dividends were also declared for various...
Sun Life Financial reported a 9% increase in underlying net income to $1.146 billion for Q3 2026, fueled by strong growth across Canada, Asia, the U.S. stop loss segment, and its GreenOak asset management business. Despite a 29% drop in reported net ...
